Skip to main content
PLOS One logoLink to PLOS One
. 2020 Aug 21;15(8):e0238094. doi: 10.1371/journal.pone.0238094

Hypoglycemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: Cross-sectional study

Esileman Abdela Muche 1,*, Banchamlak Teferi Mekonen 1
Editor: Randy Wayne Bryner2
PMCID: PMC7446928  PMID: 32822414

Abstract

Introduction

Hypoglycemia is a true medical emergency, which needs prompt recognition and treatment to prevent organ damage and mortality. Knowledge about the prevention of hypoglycemia is an important step to self-care practice because informed people are more likely to have a better hypoglycemia prevention practice. The aim of this study was to explore hypoglycemia prevention practice and its associated factors among diabetes patients at a university teaching hospital in Ethiopia.

Method

A cross-sectional study was carried out on a total of 422 systematically selected diabetic patients at the University of Gondar Referral and Teaching Hospital. Data were collected using a pre-tested, structured, and interviewer-administered questionnaire. The collected data was analyzed by SPSS version 20 and associated variables were measured using binary logistic regression and within 95% confidence interval. A p-value <0.05 was considered as statistically significant.

Result

From the total of 422 diabetic patients, 61.6% were males, 70.1% of them were urban dwellers, 37.9% of them were unable to write and read, and 70.6% of the participants were taking insulin. The majority of respondents had good knowledge of (77.5%) and practice of (93.1%) hypoglycemia prevention. Only good participant knowledge about hypoglycemia prevention was strongly associated with the practice of its prevention (AOR: 2.87 (1.2–6.8), p = 0.01).

Conclusion and recommendation

Even though diabetic patients with good knowledge of hypoglycemia and its prevention was strongly associated with good prevention practice, there exists a gap in knowledge of hypoglycemia prevention. Hence, we recommend counseling be offered to patients regarding hypoglycemia during their visit to the diabetic clinic. Counseling points such as common clinical symptoms, its negative consequence, as well as remedial options are essential elements for the improvement of their practice on its prevention.

Introduction

Diabetic Mellitus is a non-communicable heterogeneous group of metabolic disorders with elevated blood glucose and abnormally shifted carbohydrate, fat and protein metabolism resulting from defects in insulin secretion and/or insulin action [1]. Both acute and chronic complications are responsible for the death and hospitalization associated with diabetes. Hypoglycemia, which is defined as “an abnormally low plasma glucose concentration (<70 mg/dl) that exposes the subject to potential harm”, is one of the acute complications of diabetes mellitus [2, 3].

A systemic review and meta-analysis conducted among type II DM patients reported the prevalence of mild/moderate and severe hypoglycemia to be 45%, 6% respectively [4]. Another multi-center study that aimed to assess rates and predictors of hypoglycemia reported that 83.0% of patients with type I DM and 46.5% of patients with type II DM experienced hypoglycemia [5].

Hypoglycemia poses a significant economic burden on the health care system through frequent emergency room visits, ambulance utilization, and hospitalizations costs. An estimated 2–4% of people with type 1 diabetes mellitus die from this complication of DM each year [6–11].

Insulin therapy, insulin secretagogues, skipping a meal, doing physical exercise without taking food, a history of severe hypoglycemia, alcoholic beverages, renal insufficiency, coronary artery disease, and infections are the most common reasons for the recurrent episodes of hypoglycemia [12–15].

The spectrum of symptoms depends on the duration and severity of hypoglycemia and vary from autonomic activation to behavioral changes to altered cognitive function. Checking blood glucose levels is the only way to know whether a person is experiencing low blood glucose. The short and long-term complications include neurologic damage, trauma, cardiovascular events, and death [6, 12].

Hypoglycemia treatment requires the ingestion of glucose or carbohydrate-containing foods. Pure glucose is the preferred treatment, but any other form of carbohydrate which contains glucose will help to raise blood glucose. Glucagon is indicated for the treatment of hypoglycemia in people unable or unwilling to consume carbohydrates by mouth [14, 16]. However, early detection and prevention are preferred to its treatment to avoid severe negative health sequela and economic burden [17].

Effective approaches known to reduce the risk of hypoglycemia include patient education along with self-monitoring of blood glucose (SMBG), dietary modifications and regular exercise, medication adjustment, careful glucose monitoring by the patient, and conscientious follow up by the clinician [18, 19]. Moreover, knowledge about symptoms of hypoglycemia is an important step to self-care practice, because informed people are more likely to have better practice [20]. Having good knowledge about hypoglycemia is positively associated with good hypoglycemia prevention practice [21].

Several cross-sectional studies on knowledge of hypoglycemia symptoms reported as being poor or good. Research findings showed that 64.4% of diabetic patients had good knowledge of hypoglycemia [22], while some studies done in a rural population indicated that 63.33% of diabetic patients had inadequate knowledge [23]. However, some other studies showed that more than half of the study participants had knowledge about symptoms associated with hypoglycemia [24, 25]. In other study conducted in Ethiopia, 63.2% of participants had good hypoglycemia prevention practice [21]. They recommended educating the patient as one strategy to have a better practice on the prevention of hypoglycemia.

Even though there are many research works reported on self-care practice and knowledge about hypoglycemia, there are no studies done on knowledge and practice regarding hypoglycemia prevention among DM patients who are on regular follow up at the University of Gondar Referral and Teaching Hospital. Therefore, the current study aimed at assessing the status of knowledge and practices among diabetic patients towards the prevention of hypoglycemia and its complication at the University of Gondar Referral and Teaching Hospital (UoGRTH).

Methods

Study area

The study was conducted at the chronic outpatient department (OPD) of the University of Gondar Referral and Teaching Hospital (UoGRTH), which is located in Gondar town, Amhara national regional state, which is 750 km far from Addis Ababa, North-west Ethiopia. The hospital serves for more than 7 million people, who are found in central, north, and west Gondar zones and the surrounding zones and woredas. It has 680 beds and 21 wards for inpatients, emergency, and outpatient department services.

Study design and period

A hospital-based cross-sectional study was conducted from February-March 2019.

Population

Source population. All diabetic patients who were attending chronic OPD at UoGRTH.

Study population. All diabetic patients who were attending at UoGRTH chronic OPD during the study period.

Inclusion and exclusion criteria

Inclusion criteria. All adult diabetic patients who were attending chronic OPD.

Exclusion criteria. Patients who were seriously ill and unable to communicate, patients who were unwilling to participate, and women with gestational diabetes.

Sample size & sampling methods

A single population proportion formula was used to calculate sample size, n = z 2p (1-p)/d2, by considering P = 50% precession (d), 5% marginal error and 95% confidence interval. After adding a 10% contingency on the calculated 384 patients, the final sample size became 422. The daily average number of ambulatory diabetic patients visiting the outpatient department was estimated to be between 110 and 130. Systematic random sampling was done with a sampling interval of 5. Every fifth patient coming to the OPD was selected by starting from a random number.

Data collection tools

A structured questionnaire was adapted from different literatures [6, 21, 23, 26]. It consists of data regarding knowledge and practices related to the prevention of hypoglycemia, socio-demographic variables, and clinical characteristics. The knowledge assessment questionnaire has 10 questions with a maximum of 12 points which was calculated by giving one for each correct response and zero for each wrong response, except for question number three which has two correct answers; so, it has two points. The practice part of the questionnaire has 15 questions with a maximum score of 17. It was calculated by giving one for each correct response and zero for each wrong response except the first question which has two points.

Study variables

Dependent variables. Hypoglycemia prevention practice

Independent variables. Socio-demographic variables (age, sex, income, marital status, education, religion, and occupation). Clinical characteristics-related variables (body mass index (BMI), Types of DM, duration of treatment, type of medication used, frequency of taking medication, history of hypoglycemia, and co-morbidity).

Operational definitions

  • Good Knowledge: a score of > 6 on the knowledge assessment questions.

  • Poor Knowledge: a score of < 6 on the knowledge assessment questions.

  • Good Practice: a score of >8.5 on the practice assessment questions.

  • Poor practice: a score of < 8.5 on the practice assessment questions.

Data collection procedures

A structured questionnaire was developed in English and translated to Amharic, which was the language spoken by the study subjects. It was back-translated to English by another person to check for consistency. Three pharmacy technicians and one clinical pharmacist were recruited for data collection and supervision, respectively. The questionnaire was pretested on 21 diabetic patients in the same set up who were not included in the main study. The original questionnaire was modified for clarity, sensitiveness, and completeness based on the pre-test data.

Data processing and analysis

Data analysis was done by using International Business Machines Corporation, Statistical Package for the Social Sciences (IBM SPSS) version 20). Descriptive analysis was done. Frequency distribution and percentage were used to describe results on the knowledge and practice of hypoglycemia prevention. Associated factors were identified using binary logistic regression analysis. Variables with p-value of less than 0.3 from bivariate analysis were taken to multivariate logistic regression analysis and a p-value < 0.05 was considered as statistically significant.

Ethical consideration

The study was conducted after ethical approval of the proposal from the University of Gondar, School of Pharmacy ethics committee (Ref.No:SOP318/2011). A letter of cooperation was obtained from the chief medical director. Since there were so many illiterate participants and finding a witness for every illiterate individual was difficult, we took verbal informed consent from each study participant. Data was taken anonymously and kept confidential throughout the study period.

Results

Sociodemographic variables and clinical characteristics of study subjects’

A total of 422 DM patients participated in this study. The mean age of respondents was 42.23 (SD±16) years. More than half (61.6%) of them were male. Two-hundred and seventy (64%) participants were married. The majority (85.1%) of the participants were Orthodox Christian followers. Two-hundred and ninety-six (70.1%) of them were urban residents. Regarding their education status, 38.6% were illiterate and the rest completed primary school and above. Two-third (67.3%) of the study subjects had a normal BMI. Two-hundred and twenty-eight (54%) of the study subjects were type II diabetes mellitus patients and 17% of participants were comorbid with hypertension. Approximately 71% of the participant experienced insulin injection therapy and the rest were on oral hypoglycemic agents. In addition, 46.4% of the participant took their medications for more than five years (Tables 1 and 2).

Table 1. Socio demographic characteristic of study participants, UoGRTH, North-West Ethiopia, 2019 (N = 422).

Variable Classification Frequency (%)
Age 18–34 154 (36.5%)
35–64 220 (52.1%)
> 65 48 (11.4%)
Sex Male 260 (61.6%)
Female 162 (38.4%)
Residence Urban 296 (70.1%)
Rural 126 (29.9%)
Religion Orthodox 359 (85.1%)
Muslim 56 (13.3%)
Protestant 7 (1.7%)
Marital status Unmarried 97 (23%)
Married 270 (64%)
Divorced 21 (5%)
Widowed 34 (8.1%)
Educational status Unable to write and read 160 (37.9%)
Primary education 112 (26.5%)
Secondary education 87 (20.6%)
College and above 63 (14.9%)
Occupation Unemployed 102 (24.2%)
Private 100 (23.7%)
Government 85 (20.1%)
Student 35 (8.3%)
House wife 41 (9.7%)
Farmer 59 (14%)
Income per month <15USD* 263 (62.3%)
15–30 USD 49 (11.6%)
30-45USD 24 (5.7%)
>45USD 86 (20.4%)

*USD—United states dollar

Table 2. Clinical characteristics of the study participants, UoGRTH, Northwest-Ethiopia, 2019 (N = 422).

Variable Classification Frequency
BMI < 18.5 51 (12.1%)
18.5–24.5 284 (67.3%)
25–29.9 79 (18.7%)
>30 8 (1.9%)
Types of diabetes Type I 194 (46%)
Type II 228 (54%)
Duration with illness (DM) in year 1–2 102 (24.2%)
3–5 124 (29.4%)
>5 196 (46.4%)
Types of treatment Insulin 298 (70.6%)
Metformin 74 (17.5%)
Metformin + Glibenclamide 34 (8.1%)
Insulin + metformin 16 (3.8%)
Frequency of taking medication Once a day 30 (7.1%)
Twice a day 392 (92.9%)
History of hypoglycemia in the last month yes 16 (3.8%)
No 406 (96.2%)
Co-morbid condition Hypertension 75 (17.8%)
Dyslipidemia 15 (3.6%)
Hypertension and dyslipidemia 23 (5.5%)
Heart failure 2 (0.5%)
Other* 8 (1.9%)
None 299 (70.9%)

* Epilepsy, peptic ulcer disease, hyperthyroidism, stroke, constipation, endocarditis, dermatitis, osteoarthritis.

Knowledge about hypoglycemia prevention

Of all the participants, 327 of them (77.5%) had good knowledge about hypoglycemia prevention. Most (82.2%) of the participants knew about the blood glucose level below which it is termed hypoglycemia. The majority (90.5%) of the study subjects correctly answered questions with regard to the causes of hypoglycemia. Three-hundred fifty-four (83.9%) of the study subjects knew the symptoms of hypoglycemia and 295 (69.9%) of the participants knew about ways to prevent hypoglycemia (Table 3).

Table 3. Knowledge regarding hypoglycemia prevention among study subjects, UoGRTH, North-west Ethiopia, 2019 (N = 422).

Variable Good knowledge response N (%) Poor knowledge response N (%)
low blood glucose level (Hypoglycemia) 347(82.2) 75 (17.8)
Normal blood glucose level 247 (58.5) 175 (41.5)
Main cause of hypoglycemia 382 (90.5) 40 (9.5)
Risk factor for hypoglycemia 243 (57.6) 179 (42.4)
Symptoms of hypoglycemia 354 (83.9) 68 (16.1)
Symptoms of night time hypoglycemia 156 (37) 266 (63)
Complication of hypoglycemia 390 (92.4) 32 (7.6)
Ways to Prevent hypoglycemia 295 (69.9) 127 (30.1)
Prevent night time hypoglycemia 211 (50) 211 (50)
Prevent repeated hypoglycemia 193 (45.7) 229 (54.3)
Total Knowledge assessment 327 (77.5) Good Knowledge 95 (22.5) poor knowledge

Practice experience on hypoglycemia prevention

Among the respondents, 393 (93.1%) had good practice in hypoglycemia prevention. For example, the majority (87.2%) of participants responded that they carry simple sugar while traveling. Similarly, 74 (17.5%) participants reported that they monitor their blood glucose level at home, and few (8.8%) participants practiced re-testing their blood glucose after managing a hypoglycemia incident. Almost all (95.5%) of participants were adherent towards the regular appointments, and the majority (93.3%) of participants reported hypoglycemia episodes to their physician (See Table 4).

Table 4. Practice regarding hypoglycemia prevention among ambulatory diabetic patients, UoGRTH, North-west- Ethiopia, 2019 (N = 422).

Variables Good practice response N (%) Poor practice response N (%)
Have table sugar while travelling 368 (87.2) 42 (10)
Self-management of hypoglycemia 344 (81.5) 78 (18.5)
When did you experience hypoglycemia 336 (79.6) 86 (20.4)
Safe exercise to avoid hypoglycemia 390 (92.9) 30 (7.1)
Duration of exercise 278 (65.9) 144 (34.1)
Effect of weight lifting in a hypoglycemic patient 261(61.8) 161 (38.2)
Self-blood glucose monitoring at home 74 (17.5) 348 (82.5)
Measure blood glucose when you think hypoglycemic 187 (44.3) 235 (55.7)
Retest blood glucose after treatment of hypoglycemia 37 (8.8) 385 (91.2)
Taking snacks 137 (32.5) 285 (67.5)
Irregular carbohydrate diet 62 (14.7) 360 (85.3)
Coming in regular appointment 403 (95.5) 19 (4.5)
Adjust medication based on blood glucose level 243 (57.6) 179 (42.4)
Report hypoglycemia episodes to a physician 394 (93.3) 28 (6.6)
Total practice assessment 393 (93.1) Good 29 (6.9) Poor

Factors associated with practice on hypoglycemia prevention

Bivariate logistic regression analysis showed that gender (P = 0.08), educational status (P = 0.084), occupation (P = 0.013), duration of the illness (P = 0.082), the type of treatment given (P = 0.046), and the level of knowledge about prevention of hypoglycemia (p = 0.001) were factors possibly associated with the practice of hypoglycemia prevention. However, only the level of knowledge of hypoglycemia prevention showed statistically significant association (p = 0.01; AOR: 2.87 95%CI (1.2–6.8) on multivariate regression (See Table 5).

Table 5. Factors associated with hypoglycemia prevention practice among study subjects, UoGRTH, North-west- Ethiopia, 2019 (N = 422).

Variable Practice regarding prevention of hypoglycemia P value COR AOR (95% CI) P value
Good (393) N (%) Poor (29) N (%)
Age 0.55
18–34 145 (36.9) 9 (31) 0.28 1.00
35–64 205 (52.2) 15 (51.7) 0.39 0.533
>65 43 (10.9) 5 (17.2) 0.00 0.629
Sex
Male 249 (63.4) 11 (37.9) 0.008 0.353 2.39 0.10
Female 144 (36.6) 18 (62.1) 9
Residence
Urban 277 (70.5) 19 (65.5) 0.573 0.795
Rural 116 (29.5) 10 (34.5)
Marital status 0.396
Unmarried 94 (23.9) 3 (10.3) 0.187 1.00
Married 248 (63.1) 22 (75.9) 0.892 0.329
Divorce 20 (5.1) 1 (3.4) 0.578 0.916
Widowed 31 (7.9) 3 (10.3) 0.000 0.516
Educational status 0.084
Unable to write and read 143 (36.4) 17 (58.6) 0.075 1.00 2.53 0.182
Primary education 107 (27.2) 5 (17.2) 0.033 0.393 6.80 0.061
Secondary education 85 (21.6) 2 (6.9) 0.545 0.197 1.83 0.539
Graduate 58 (14.8) 5 (17.2) 0.000 0.725
Occupation 0.013 2.59 0.25
Unemployed 98 (24.9) 4 (13.8) 0.426 1.00 1.27 0.77
Private employed 96 (24.4) 4 (13.8) 0.443 0.561 0.55 0.60
Government employed 79 (20.1) 6 (20.7) 0.948 0.572 0.59 0.65
Student 33 (8.4) 2 (6.9) 0.838 1.044 0.57 0.51
House wife 32 (8.1) 9 (31) 0.034 0.833
Farmer 55 (14) 4 (13.8) 0.000 3.867
Income 0.871
<15USD 244 (62.1) 19 (65.5) 0.938 1.00
15-30USD 47(12) 2 (6.9) 0.498 1.03
30-45USD 22 (5.6) 2 (6.9) 0.821 0.56
>45USD 80 (20.4) 6 (20.7) 0.000 1.21
BMI
<18.5 40 (12.2) 11 (11.6) 0.844
18.5–24.9 220 (67.3) 64 (67.4)
25–29.9 62 (19) 17 (17.9)
>30 5 (1.5) 3 (3.2)
Type of DM
Type I 183 (46.6) 11 (37.9) 0.370 0.70
Type II 210 (53.4) 18 (62.1)
Diabetic duration in year 0.082
1–2 92 (23.4) 10 (34.5) 0.634 1.00 0.40 0.07
3–5 121 (30.8) 3 (10.3) 0.046 1.22 3.70 0.05
>5 180 (45.8) 16 (55.2) 0.00 0.27
Type of treatment 0.046
Insulin 279 (71) 19 (65.5) 0.349 1.00 1.77 0.51
Metformin 72 (18.3) 2 (6.9) 0.115 0.47 8.06 0.08
Metformin + glibenclamid 28 (7.1) 6 (20.7) 0.644 0.19 0.64 0.66
Insulin + metformin 14 (3.6) 2 (6.9) 0.010 1.50
Frequency of taking medication
Once a day 29 (7.4) 1 (3.4) 0.438 0.44
Twice a day 364 (92.9) 28 (96.6)
History of hypoglycemia
Yes 173 (44) 12 (41.1) 0.782 0.89
No 220 (56) 17 (56.2)
Comorbid condition 0.443
Hypertension 90 (22.9) 8 (27.5)
Dyslipidemia 32 (8.1) 6 (20.6)
Heart failure 19 (4.8) 4 (13.8)
other 10 (2.5) -
None 280 (71.2) 19 (65.5)
Level of knowledge
Good 312 (79.3) 15 (51.7) 0.001 0.27 2.87 0.01
Poor 81 (20.6) 14 (48.2) (1.2–6.8)

P value < 0.05 considered as scientifically significant

Discussion

Hypoglycemia can cause serious morbidity and even death if it is severe and prolonged. Due to the deprivation of glucose in the central nervous system, the primary clinical symptoms are neuroglycopenic presentations such as confusion, fatigue, and loss of consciousness. The purpose of this study was to assess the knowledge and practice of hypoglycemic prevention of patients with diabetes mellitus. In this study, we found that more than two-thirds (72.7%) of the participants had good knowledge about hypoglycemia prevention. This finding is higher than the study conducted in South Gondar, Ethiopia (25.5%). This may be due to the fact that there is an increasing public awareness about their health status due to civilization and an increase in media coverage. The other possible reason might be differences in study participants and the study setup. Our study is conducted in a comprehensive and specialized hospital which is a university teaching hospital with a better quality of care [26]. Our current finding is slightly higher than the study conducted in South Africa (66.1%). This difference may be due to differences in patient demographics and possibly in time [25].

The knowledge of most of the study participants (82.2%) regarding low blood glucose levels (hypoglycemia) was good. This result is higher than the report from Ludhiana, India (60%) [27]. Less than half of the participants in our study (42.4%) were unaware of the risk factors for hypoglycemia. This is comparable with one study from India (43.4%) but slightly higher than another report from the same country (32%) [5, 28].

With respect to the knowledge of hypoglycemia symptoms, the majority of the current study subjects (83.9%) had good knowledge. It was higher when compared to the report from KwaZulu-Natal, South Africa (66%), and Karnataka, India (65%) [25, 28]. These differences may be due to differences in participants’ demographics. There were more literate participants in our study (62%) than the Indian study (48%).

The majority (92.4%) of the current study participants had good knowledge about the complications of hypoglycemia which was higher when compared to the study conducted from south India which reported good knowledge for only one-third of the studied subjects. This might be due to the small sample size used in the latter study [29].

The majority (93.1%) of the study subjects had a good hypoglycemia prevention practice. This figure is higher than the report from south Gondar, Ethiopia (21.4%) and Tigray, Ethiopia (63.2%) [21, 26]. This difference might be due to the high accessibility of health care providers with specialty care in the current hospital.

With respect to the question “the practice on prevention of hypoglycemia while traveling”, more than two-third of the current study participants (87.2%) had a good practice. This was higher than the report from south Gondar Ethiopia (36.3%) [26]. This difference can be explained from different perspectives. The time-gap between the study periods is one possible reason. There was increased access to health care facilities since the latter study had been conducted. Additionally, there were differences in the study setups, and most importantly, there was a huge knowledge difference about hypoglycemia among study subjects in the two studies.

Most of the current study subjects (81.5%) had good knowledge of self-management practices for hypoglycemia by immediate consumption of glucose (simple sugar). This is slightly higher than the study reported from Nigeria (67.6%) [30]. Forty-six percent of the study participants were diabetic for more than 5 years.

Self-monitoring of blood glucose (SMBG) was practiced by 74 (17.5%) of the current study subjects. This figure was in line with the study reported from South India (15%) and was lower than the study reported from South Africa (34%). This difference might be due to differences in health care setup and study subjects’ literacy levels [29, 25]. The majority (95.5%) of participants had good practice with respect to adhering to appointment periods. Almost similar study findings were reported from south Gondar, Ethiopia (93.3%) [26].

Self-adjustment of medications was reported by more than half (57.6%) of the current study subjects which was higher compared to that of the South African (43%) and Indian (17%) studies [25, 28]. The difference may be due to the small sample size of these latter studies. The majority (93.3%) of study participants had a good practice of reporting hypoglycemic episodes to their doctors. This figure is higher compared to the study conducted in south India (48.6%) [29].

A small number (17.5%) of the current study subjects had a glucometer at their home. This was higher compared to the study report from south India (5%) and Gondar, Ethiopia (7.7%). However, it was lower than the study reported from Kwazulu-Natal, South Africa (24%), and the study report from Qatar (60.5%). This might be due to the differences in patients’ economic status and their awareness regarding the importance to practice SMBG [29, 26, 31, 32].

Seventy-four (17.5%) of the current study participants reported their ability to self-monitor their glucose levels at home, even though 243 (57.6%) patients reported that they practiced self–adjustment of their medications at home. This finding suggests that some patients were self-adjusting their medication at home based on how they feel, without objectively measuring their blood sugar. This may put them at risk of developing hypoglycemia or hyperglycemia. There is a need for the provision of education about medication adjustment in DM patients [33].

In the current study, only having a good knowledge regarding hypoglycemia prevention was strongly associated with good hypoglycemia prevention practice (p = 0.01; AOR: 2.87). This means that patients with good knowledge were 2.87 times more likely to practice hypoglycemia prevention measures as compared to those patients with poor knowledge. This finding was in line with the study reported from Tigray, Ethiopia [21]. This result suggests that knowledge about hypoglycemia prevention is essential to practice hypoglycemic prevention measures.

Twenty-eight of the current study participants were hypoglycemic at the time of hospital visit which gave a prevalence of 6.6%. This was lower than different studies in the United States which reported prevalence of hypoglycemia range from 12% to 18%.This may be due to differences in the life style of the study participants between the studies. In the current study, we only used the patients’ blood glucose level which they have at hand when they came for follow up. But the other studies took reported cases of hypoglycemia retrospectively [3, 31].

Even though participants had good knowledge and practice of hypoglycemia prevention strategies, a high number of participants had practice of hypoglycemia prevention without adequate knowledge of hypoglycemia prevention. This may be due to some participants may practice to prevent hypoglycemia by family support and asking some persons and even sometimes the try something by their assumption the other possible reason may be the knowledge questions were somehow it needs scientific knowledge.

Limitation

The study design was cross-sectional. Therefore causal modeling could not be attempted. The participants were recruited from one medical center and patients who have regular visits in northwest Ethiopia. Therefore, the findings may not be generalizable to all DM patients. Future studies with a larger and more representative sample size that include patients with gestational DM and pediatric patients with DM is required.

Conclusion

In conclusion, the practices of hypoglycemia prevention strategies among ambulatory diabetic patients were good. Knowledge of hypoglycemia prevention strategies and its practice are essential elements for control of hypoglycemia and hypoglycemic crisis. Good knowledge of hypoglycemia prevention was strongly associated with its prevention practice.

Recommendation

The current study showed that there are still gaps with respect to knowledge about hypoglycemia prevention and its practice. Therefore, we recommend providing education about hypoglycemia in general, its complication, its treatment, and prevention strategies when they came for follow up. We recommend that this study to be done in Ethiopia as a whole so will yield an accurate result.

Supporting information

S1 File

(DOCX)

Acknowledgments

We would like to thank The Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar for giving us the opportunity to do these research. And most importantly we would like to thank our participants.

Lists of abbreviation

AOR

Adjusted Odd Ratio

BMI

Body Mass Index

COR

Crude Odd Ratio

CI

Confidence Interval

DM

Diabetes Mellitus

OPD

Out-Patient Department

SD

Standard Deviation

SMBG

Self- Monitoring Of Blood Glucose

UoGCSH

University of Gondar Comprehensive and Specialized Hospital

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Thomas N, Jeyaraman K, Asha HS, Velavan J. A practical guide to diabetes mellitus. JP Medical Ltd; 2012. October 30. [Google Scholar]
  • 2.Roglic G. WHO Global report on diabetes: A summary. International Journal of Non communicable Diseases. 2016. April 1;1(1):3. [Google Scholar]
  • 3.American Diabetes Association. Work group on Hypoglycaemia. Defining and reporting hypoglycaemia in diabetes: a report from the American Diabetes Association Work group on Hypoglycaemia. Diabetes Care. 2005;28(5):1245–9. 10.2337/diacare.28.5.1245 [DOI] [PubMed] [Google Scholar]
  • 4.Edridge CL, Dunkley AJ, Bodicoat DH, Rose TC, Gray LJ, Davies MJ, et al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PloS one. 2015;10(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Khunti K, Alsifri S, Aronson R, CigrovskiBerković M, Enters‐Weijnen C, Forsén T, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study. Diabetes, Obesity and Metabolism. 2016. September;18(9):907–15. 10.1111/dom.12689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Prameela A. (2016) A study to assess the awareness on management of hypoglycaemia among diabetic clients in PSG hospitals, Coimbatore in view of preparing an information booklet (Doctoral dissertation, PSG College of Nursing, Coimbatore).
  • 7.Lingvay I. Hypoglycemia in type 2 diabetes-consequences and risk assessment. US endocrinology. 2011. December;7(2):95–102. [Google Scholar]
  • 8.Fonseca V, Chou E, Chung HW, Gerrits C. Economic burden of hypoglycaemia with basal insulin in type 2 diabetes. Am J Manag Care. 2017; 23: 114–122. [PubMed] [Google Scholar]
  • 9.Foos V, Varol N, Curtis BH, Boye KS, Grant D, et al. Economic impact of severe and non-severe hypoglycaemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ. 2015; 18: 420–432. 10.3111/13696998.2015.1006730 [DOI] [PubMed] [Google Scholar]
  • 10.Feleke Y, Enquselassie F. Cost of hospitalization of diabetic patients admitted at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiopian medical journal. 2007. July;45(3):275–82. [PubMed] [Google Scholar]
  • 11.Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycaemic disorders: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2009;94(3):709–28. [DOI] [PubMed] [Google Scholar]
  • 12.Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA internal medicine. 2014. February 1;174(2):259–68. 10.1001/jamainternmed.2013.12963 [DOI] [PubMed] [Google Scholar]
  • 13.Lin YY, Hsu CW, Sheu WH, Chu SJ, Wu CP, Tsai SH. Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. Yonsei medical journal. 2010. May 1;51(3):367–74. 10.3349/ymj.2010.51.3.367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tomky D. Detection, prevention, and treatment of hypoglycemia in the hospital. Diabetes Spectrum. 2005. January 1;18(1):39–44. [Google Scholar]
  • 15.Kahsay H, Fantahun B, Nedi T, Demoz GT. Evaluation of Hypoglycemia and Associated Factors among Patients with Type 1 Diabetes on Follow-Up Care at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Journal of diabetes research. 2019;2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Glycaemic Targets: Standards of Medical Care in Diabetesd, 2018. Diabetes Care. 2018 Jan 1;41:S55. [DOI] [PubMed]
  • 17.Griffing KL. Hypoglycemia Prevention in Hospital Patients: A Quality Improvement Project to Prevent Severe and Recurrent Hypoglycemia. Clinical Diabetes. 2016. October 1;34(4):193–9. 10.2337/cd15-0055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Seaquist ER, Anderson J, Childs B, et al. Hypoglycaemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 2013;36(5):1384–1395. 10.2337/dc12-2480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sanjay K., Jagat J., Mukherjee S. et al (2013) hypoglycaemia: The neglected complication Indian Journal of Endocrinology and Metabolism Vol 17 | Issue 5 10.4103/2230-8210.117219. [DOI] [PMC free article] [PubMed]
  • 20.Peyrot M, Rubin RR (1994) Modelling the effect of diabetes education on glycaemic control. Diabetes Educ 20: 143–148. 10.1177/014572179402000210 [DOI] [PubMed] [Google Scholar]
  • 21.Gebremichael GB, Mariye Zemicheal T. Hypoglycemia Prevention Practice and Associated Factors among Diabetic Patients on Follow-Up at Public Hospitals of Central Zone, Tigray, Ethiopia, 2018. International Journal of Endocrinology. 2020. March 13;2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sharma SK, Kant R. Awareness of Symptoms and Early Management of Hypoglycemia among Patients with Diabetes Mellitus. Journal of Diabetes and Endocrinology Association of Nepal. 2017;1(1):12–7. [Google Scholar]
  • 23.Thenmozhi p, vijayalakshmi m.(2017) knowledge on hypoglycaemia among patients with diabetes mellitus asian j pharm clin res, vol 11, issue 1, 2018, 236–239.
  • 24.Tanjia N, Fannana T, Naved M, Sultana S. Assessing the Knowledge, Attitude, and Practice of Diabetes Mellitus among Diabetes Patients in Dhaka City. Bangladesh. Journal of Pharmaceutical, Chemical and Biological Sciences. 2016. April;4(1):64–75. [Google Scholar]
  • 25.Ejegi A, Ross AJ, Naidoo K. Knowledge of symptoms and self-management of hypoglycaemia amongst patients attending a diabetic clinic at a regional hospital in KwaZulu-Natal. Afr J Prm Health Care Fam Med. 2016;8 (1), a906 10.4102/phcfmv8i1.906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nega G, Getahun A., Alemie G.et al. Knowledge and practice on prevention of hypoglycaemia among diabetic patients in South Gondar, Northwest Ethiopia: Institution based cross-sectional study, Integr Obesity Diabetes, 2015. 10.15761/IOD.1000113 [DOI] [Google Scholar]
  • 27.Gulabani M, John M, Isaac R. Knowledge of diabetes, its treatment and complications amongst diabetic patients in a tertiary care hospital. Indian J Community Med 2008; 33:204–6. 10.4103/0970-0218.42068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sajja Jayashree, Manjunatha S N (2019) Awareness about hypoglycemia among patients on insulin therapy in a tertiary care hospital: A cross-sectional study International Journal of Medical Science and Public Health 10.5455/ijmsph.2019.1235509012019
  • 29.Shriraam V, Mahadevan S, Anitharani M, Jagadeesh NS, Kurup SB, Vidya TA, et al. Knowledge of hypoglycaemia and its associated factors among type 2 diabetes mellitus patients in a Tertiary Care Hospital in South India. Indian J EndocrMetab 2015; 19:378–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Iloh GU, Amadi AN. Epidemiology of hypoglycaemia among ambulatory Type 2 diabetic patients in a primary care clinic of a tertiary hospital in South-eastern Nigeria. Journal of Health Research and Reviews. 2018. May 1;5(2):57. [Google Scholar]
  • 31.Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper-and hypoglycaemia among inpatients with diabetes: a national survey of 44 US hospitals. Diabetes care. 2007. February 1; 30(2):367–9. 10.2337/dc06-1715 [DOI] [PubMed] [Google Scholar]
  • 32.Mesmar M, Eljack A, Al-Kuwari MG. Knowledge and Practice of Type 2 Diabetic Patients Attending Primary Health Care in Qatar. Middle East Journal of Family Medicine. 2011. May 1; 9(4). [Google Scholar]
  • 33.Kannan K. Evaluation of nerve conduction abnormalities and brainstem auditory evoked potentials in type 2 diabetes mellitus (Doctoral dissertation, Madras Medical College, Chennai) 2011. [Google Scholar]

Decision Letter 0

Randy Wayne Bryner

11 Dec 2019

PONE-D-19-25882

Knowledge and practice of diabetic patients towards prevention of hypoglycaemia at UoGCSH:

cross-sectional study

PLOS ONE

Dear Mr Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has multiple problems and must be completely re-written if it is to be considered. A much more focused introduction and discussion must take place. The authors are strongly encouraged to carefully read the comments of both reviewers and answer each in a revised manuscript. The authors are also encouraged to have a native English- speaking  individual fully proof the revision before it is submitted.

We would appreciate receiving your revised manuscript by Jan 25 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you still have some overlapping text with previous publications:http://www.ijem.in/text.asp?2013/17/5/819/117219 and

https://doi.org/10.4102/phcfm.v8i1.906, which needs to be addressed. In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

In the ethics statement in the Methods and online submission information, please ensure that you have specified what type of consent you obtained (for instance, written or verbal).

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

5. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

Additional Editor Comments (if provided):

The research has the potential to be informative and add to the existing body of knowledge in this field but not in the present form as written in the submitted manuscript. A complete rewrite is necessary focusing specifically on the many good suggestions from the two reviewers. Each section (introduction, methods, results and discussion) must be refocused and rewritten. In addition, as both reviewers have stated, a minimum threshold score to consider as good knowledge or good practice must be used and justified. The authors are encouraged to collaborate with a statistician for this endeavor.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review your manuscript. This study assessed knowledge and practice of preventing hypoglycemia in patients with diabetes in Gondar, Ethiopia. While the topic is interesting and should be explored, there were some limitations of the present study.

The introduction presents a nice review on hypoglycemia, but it needs to better connect to relevant literature in the area of knowledge and practice of preventing hypoglycemia. The justification for conducting this study is lacking. In the final paragraph the authors refer to previous studies – this should be expanded and these studies should be referenced. Describing the current state of understanding (from scientific literature) regarding knowledge and practice of hypoglycemia needs to be expanded in the introduction to better justify the purpose of this study in this population.

The methods – in study area and period “Diabetic patients get service two days per week” is unclear – what service is performed? Acronyms (OPD) are used within the text before spelling out their meaning. Was the questionnaire validated? As it reads now, I think there are two parts to the questionnaire – knowledge and practice – but it does not read clearly. The last sentence explains there were two categories –good and poor. The methods indicate this is based on the mean score of that section – but there’s no justification for this as the cutoff. It seems it should be more directly related to poor hypoglycemic knowledge or practice rather than based on the sampled population? Working with a statistician could allow for analysis to identify a proper cut off from the data since some individuals did present with hypoglycemia. Data collection procedures -indicates questionnaire is from previous studies but that needs to be referenced.

Results – data in the figures is also presented in the table and text. Results should be selectively presented in a single format. I would also encourage you to work with a statistician - there are several analyses that could be run with this data that might be more informative than simple descriptive statistics.

The discussion does not connect the present study to previous findings. Rather than presenting the numbers and prevalence other researchers have found, the discussion needs to connect to this work and provide an interpretation of the results. It should connect back to the original justification. Once the justification is clearly written in the introduction, connecting back to it in the discussion and using literature to support your interpretation will strengthen the manuscript. As it is now, the discussion is insufficient.

Finally, I encourage you to have this proof read by a native English speaker before resubmitting.

Reviewer #2: The authors completed a cross-sectional study at an outpatient hospital facility in Ethiopia to determine prevalence of hypoglycemia and patients’ level of knowledge about hypoglycemia and their use of various practices to prevent hypoglycemia. They discuss the results in relationship to other similar published studies and, despite a low prevalence of hypoglycemia in the study population, recommend patient education related to prevention of hypoglycemia.

This article has the potential to contribute important knowledge to the scientific literature, but not in its current form. The purpose of the study is based on the premise that this information hasn’t been collected before in this population, and that knowledge of hypoglycemia is related to better prevention of hypoglycemia. While this is a cross-sectional study and is limited in the potential to determine causality, as stated by the authors in their limitations section, the relationship between a patient’s knowledge score and their practice score could be investigated with these data (but is not).

As presented, the results of this study are difficult to interpret and do not seem to fully support the claim that the study group has good knowledge of hypoglycemia and practice on hypoglycemia prevention. The experimental methods and results are not described in sufficient detail. The authors state that the study questionnaire was used in another published study, but it is unclear as to whether the questionnaire is validated to measure what it is intended to measure. Additionally, the results need to be more detailed; specifically, the mean score for each component of the knowledge and practice score should be included in tables 3 and 4 so that the reader can understand how the whole group fares in terms of knowledge and practice of hypoglycemia prevention. This is important because the authors present the results as “good” or “poor” knowledge and practice based on how each individual score compares to the mean score of the group, but the results really don’t show whether or not the subjects have good or poor knowledge of hypoglycemia/prevention – they just show the proportion of the group that falls above the mean and the proportion that falls below the mean. If the entire sample group has limited knowledge and practice of hypoglycemia prevention (i.e. the mean is a low score out of the maximum), even scores that are less than half of the maximum could be considered “good” knowledge or practice scores. It seems that setting a minimum threshold score to consider as “good” knowledge or “good” practice would be a better way to present these results. Furthermore, it is unclear where the estimate that “72.7% of participants had good knowledge in hypoglycemia prevention” (line 1 of the discussion) came from, and similarly how the authors came to the conclusion that “93.1% of the patients had good practice” (discussion paragraph 3, line 1). These numbers are not indicated in the results in tables 3 or 4.

Finally, figures 1 and 2 are unnecessary and add no additional information beyond what is included in tables 1 and 2; they should be removed.

The discussion requires a revision for clarity - is messy and difficult to follow. Also, the authors attribute much of the differences between the findings in their study and the findings of other studies to differences in sample size. This should either be elaborated on, or more thoughtful discussion of potential reasons for disparate results should be considered. Are the authors suggesting that the other studies were not adequately powered to detect differences between their study groups? How specifically does this affect the interpretation of these results compared to other studies?

Overall, the writing is unintelligible in many places and requires significant editing to be acceptable for publication. There are numerous errors that require revision – including capitalization, punctuation, syntax, and grammatical errors – too many to type here.

Lastly, and importantly, multiple references are not cited in the manuscript, including references 1, 11, 12, 16, 17, 19, 20, 21, 28, 29, 31, and 32. Either the references should be removed from the reference list, or the manuscript should be updated to include the proper citations for these sources.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 21;15(8):e0238094. doi: 10.1371/journal.pone.0238094.r002

Author response to Decision Letter 0


15 Feb 2020

editores comment is adressed. submitted the required three document revized manuscript, revized manuscript with trackchange and response to reviwers comment.

Journal requirment was corrected as follows

1. manuscript meets PLOS ONE's style requirements, including those for file naming.

2. rephrased any duplicated text outside the methods section.overlapping text with previous publications were revized. the consent is verbal i included in the text.

3.I already included additional information regarding the survey or questionnaire used in the study. Supporting files were attached as per recommendation

4. About ethics statment--- I removed ethics ststment form any other site except in the method section.

5. Tables are now part of manuscript

reviwers comment

1. first question I tried to make scientifically sound with rewritten of introduction and discussion part and proof reeding

2. Has the statistical analysis been performed appropriately and rigorously? Now i made analysis to find out associated factors with binary logestic regression analysis. Finally new table was made and appropraitely interpreted.

3. Is the manuscript presented in an intelligible fashion and written in standard English? I completely proff read and re written to make it easy to understand.

reviwers comment was adressed and attached as per request.

Attachment

Submitted filename: Rebuttal letter.docx

Decision Letter 1

Randy Wayne Bryner

26 Mar 2020

PONE-D-19-25882R1

Hypoglycaemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: cross-sectional study

PLOS ONE

Dear Mr Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We thank the authors for their revised manuscript but there are still some issues that must be addressed. Please answer each of the comments made in the review. Additionally, the manuscript still needs to be thoroughly reviewed by a native English speaking person.

We would appreciate receiving your revised manuscript by May 10 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for revising your manuscript. The introduction still does not fully justify this study - if you're running multivariate regressions it indicates you're trying to find predictors - that needs to be included in the introduction. In the current version the operational definitions are still unclear. You state that Poor knowledge or practice is when patients scored below 50% of the mean score. That implies that 50% of the population will have "good" and the other half will have "poor" knowledge or practice. The threshold for good and bad should not be based on the population - if the entire sample scores <25% correct that would suggest nobody had good practice or knowledge, but according to your operational definition the top 50% would still be classified as "good". However, when reading the results it seems this is not, in fact, how you are using "good" or "poor" since 77.% had good knowledge of hypoglycemia prevention. Please clarify your operational definition. The units of birr will not make sense to readers outside of the study area - perhaps you could stratify based on the average income of the area. The limitation section acknowledges that these findings are limited to the region under study, but it's also limited to patients that regularly visit the hospital. There are likely a great number of individuals with diabetes that do not visit the clinic regularly and are therefore less likely to be monitoring blood sugar. This manuscript still needs to be revised and proofread by a native English speaker.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 21;15(8):e0238094. doi: 10.1371/journal.pone.0238094.r004

Author response to Decision Letter 1


4 May 2020

Response to reviewer

1. Introduction should include predictors to hypoglycemia prevention practice.

� As far as investigators knowledge there is no literatures which showed predictors of hypoglycemia prevention practice except reference 21 and 26. And these reference are reviewed under paragraph 8 under introduction.

2. Operational definition still unclear?

Now it becomes clarified

� Good Knowledge: when patients scored > 6 on the knowledge assessment questions.

� Poor Knowledge: when patients scored < 6 on the knowledge assessment questions.

� Good Practice: when patients scored >8.5 on the practice assessment questions.

� Poor practice: when patients scored < 8.5 on the practice assessment questions.

3. Economic status should be stratified based on the average income and change to international currency.

� This stratification is based on the study area salary scale. But we changed with USD by considering current currency exchange.

4. These findings are limited to the region under study, but it's also limited to patients that regularly visit the hospital.

� Accepted and stated to limitation part this study.

Attachment

Submitted filename: Response to reviewer.docx

Decision Letter 2

Randy Wayne Bryner

27 May 2020

PONE-D-19-25882R2

Hypoglycaemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: cross-sectional study

PLOS ONE

Dear Dr. Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In particular, there are several typing and grammatical errors, etc. that detract from the scientific merit of this work. For the manuscript to be consider it is imperative that it be thoroughly reviewed and edited by a native English speaker.

Please submit your revised manuscript by Jul 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for addressing and sufficiently responding to the requested revisions. Other than a careful review and edit by a native English speaker I have no other comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 21;15(8):e0238094. doi: 10.1371/journal.pone.0238094.r006

Author response to Decision Letter 2


7 Jun 2020

Reviewer #1: Thank you for addressing and sufficiently responding to the requested revisions. Other than a careful review and edit by a native English speaker I have no other comments.

As stated above Ousman Abubeker who is fluent in English language thoroughly reviewed and now I revised according to his comment.

Attachment

Submitted filename: Response to reviewer.docx

Decision Letter 3

Randy Wayne Bryner

12 Jun 2020

PONE-D-19-25882R3

Hypoglycaemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: cross-sectional study

PLOS ONE

Dear Dr. Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

It appears that the authors are ignoring the reviewers comments to have the manuscript carefully edited by a native English speaking individual. There are still several grammatical mistakes that need to be corrected before it can be considered for publication.

Please submit your revised manuscript by Jul 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 21;15(8):e0238094. doi: 10.1371/journal.pone.0238094.r008

Author response to Decision Letter 3


26 Jun 2020

manuscript carefully edited by a native English speaking individual. I did it as I mentioned it above.

no more comment from reviewer.

Attachment

Submitted filename: Response to reviewer.docx

Decision Letter 4

Randy Wayne Bryner

11 Aug 2020

Hypoglycemia prevention practice and its associated factors among diabetes patients

at university teaching hospital in Ethiopia: cross-sectional study

PONE-D-19-25882R4

Dear Dr. Muche,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Randy Wayne Bryner, Ed.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional): Thank you for your careful review and corrections of the grammatical concerns and English issues. 

Reviewers' comments:

Acceptance letter

Randy Wayne Bryner

13 Aug 2020

PONE-D-19-25882R4

Hypoglycemia prevention practice and its associated factors among diabetes patients at university teaching hospital in Ethiopia: cross-sectional study

Dear Dr. Muche:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Randy Wayne Bryner

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: Rebuttal letter.docx

    Attachment

    Submitted filename: Response to reviewer.docx

    Attachment

    Submitted filename: Response to reviewer.docx

    Attachment

    Submitted filename: Response to reviewer.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES